🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For friends at #ASH2024 - I’ll be presenting our work on CH infiltrating the solid tumour microenvironment at poster 1287 tonight at 5:30. Please stop by if you’re interested in learning more!

Did you know 1 in 5 lung cancer patients may ALSO have ​#ClonalHematopoiesis?🩸🫁 Knowing this could transform patient prognosis & treatment decisions. Catch my pitch📍Sun, Dec 10 | 7:30–10 PM PT | Luce Loft. Grateful to CHS Chief Resident & my team Michael Rauh for the support! #ASH24

An absolute honour to present an update on my research at #ASH2024 Thank you times 100 to my mentors, Sherine Elsawa and Michael Rauh for their support in this work, and ASH for the HONORS award funding. Looking forward to #ASH2025 already! 🩸

Congratulations David Lillicrap !🎉 Very well-deserved! Proud to be your student.

Today we celebrate the International Day of Women & Girls in Science. We, at Sinclair Cancer Research Institute, feel privileged to have such extraordinary women conducting essential research here! Kudos to them! 👏👏👏 #WomenInScience Queen's Health Sciences Research@Queen's University Queen's University

Celebrating #WomenInSTEM today and every day! 🌟 International Day of Women and Girls in Science highlights the contributions women and girls make in shaping the future of science and innovation. Let’s continue to support and empower the next generation of scientists! #IDWGS

I'm super excited to share that our work on clonal hematopoiesis in the tumour microenvironment is now published in Cell Reports Medicine!! By tracking CH mutations from the blood into the tumour (CH-Tum), we uncovered some new insights about CH in solid cancer cell.com/cell-reports-m…

Online now: Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes dlvr.it/TJKG3R

On the heels of our two collaborative studies connecting clonal hematopoiesis to kidney outcomes (journals.lww.com/jasn/abstract/… & journals.lww.com/jasn/abstract/…), delighted to share our review synthesizing the evidence to-date on clonal hematopoiesis and kidney disease led by Zhi Yu

Diabetes drug for preventing blood cancer? Our study in nature shows potentials to repurpose metformin to reduce risks of blood cancers & inflammatory illnesses in clonal hematopoiesis patients with DNMT3AR882 mutations. University Health Network Princess Margaret Cancer Centre UHN Research doi.org/10.1038/s41586…

Congratulations to Alex McDonald, MSc'25 (Candidate) (Left) as the 2024-25 recipient of the AMS- Christopher Knapper Award for Excellence in Teaching. Queen's U Department of Medicine Queen's Health Sciences Michael Rauh

New evidence today NEJM that age-related clonal hematopoiesis (CHIP) has a driver role in evolution of solid cancers nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…

Phenomenal paper from Oriol Pich Elsa Bernard out in NEJM exploring tumour-infiltrating clonal hematopoiesis! Many interesting findings complementary to our work in Cell Reports Medicine connecting TI-CH/CH-Tum with worsened clinical outcomes and dysregulated myeloid immunity

Genetics meets Epigenetics: TET2 mutations (encoding the enzyme that demethylates genes) promote pulmonary arterial hypertension & panchromosomal hypermethylation. The hypermethylated genes may alter T cell function Charlie Hindmarch @QueensuTIME Comp Physiol dx.doi.org/10.1002/cph4.7…

Healthspan has a proteomic signature! About 3,000 plasma proteins assessed and validated in 2 cohorts. Immune response and inflammation proteins stood out. pnas.org/doi/10.1073/pn…

Collaborative work online now Cell Stem Cell provides insight into how mutant immune cells can help mitigate Alzheimer’s disease. Tet2-mutant myeloid cells are able to infiltrate the brain and clear β-amyloid, slowing cognitive decline. cell.com/cell-stem-cell…

Congrats & thanks to Katherine King & Katie Matatall Katherine King MDPhD for inviting us to this collaboration Cell Stem Cell. Also to Alex McDonald, Marco Buttigieg , Caitlyn Vlasschaert & Susan Crocker Queen's Health Sciences Translational Medicine Graduate Program Queen's MD/PhD . Our funding from #NFRF SSHRC, CIHR